CreatorDB | $47,000,000 | (Sep 17, 2025)
Vega(US) | $65,000,000 | (Sep 17, 2025)
Eve Security | $3,000,000 | (Sep 17, 2025)
Certified by Founder
Lodge
Sionna Therapeutics
start up
United States
- Boston, MA
- 07/03/2024
- Series C
- $182,000,000
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- Industry Biotechnology
- Website https://www.sionnatx.com/
- LinkedIn https://www.linkedin.com/company/sionna-therapeutics/
Ethosphere | $2,500,000 | (Sep 17, 2025)
Trially AI | $4,700,000 | (Sep 17, 2025)
Bubo² | $2,000,000 | (Sep 17, 2025)
AllRock Bio | $50,000,000 | (Sep 17, 2025)
Overmind | $6,000,000 | (Sep 17, 2025)
BIOWEG | $18,970,160 | (Sep 17, 2025)
Plumerai | $8,700,000 | (Sep 17, 2025)
Hiverge | $5,000,000 | (Sep 17, 2025)
uiAgent | $4,600,000 | (Sep 16, 2025)